Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Frequency of Helicobacter Pylori Hopqi, Hopqii and Saba Genes Among Iranian Patients With Gastroduodenal Diseases Publisher



Sedarat Z1, 2 ; Khashei R3 ; Shirzad H1 ; Bagheri N4 ; Sadeghiani M1 ; Shahi H1 ; Zamanzad B1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
  2. 2. Basic Sciences of Center, Shahid Dooran Pardis, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  4. 4. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Jundishapur Journal of Microbiology Published:2018


Abstract

Background: Helicobacter pylori has been recognized as the most common pathogen of human gastroduodenal tract and it has been suggested that adhesins, including HopQ and SabA, are associated with the organism’s virulence. Objectives: The current study aimed at determining the frequency of hopQI, hopQII, and sabA genes among H. pylori isolates from patients with gastroduodenal disorders in Shahrekord, Iran. Methods: Gastric corpus samples were obtained from 150 symptomatic patients admitted to the endoscopy unit at gastroenterology clinic. After DNA extraction from all corpus samples, H. pylori molecular confirmation and genotyping was performed by the polymerase chain reaction (PCR), using specific primers for glmM, 16SrRNA and hopQ, sabA genes, respectively. Results: The hopQI, hopQII, and sabA genes were found in 74 (49.3%), 59 (39.3%), and 43 (28.7%) cases, respectively. The hopQI gene was detected in 75% of patients with gastric cancer (GC), 42.4% with chronic gastritis (CG), and 57.4% with peptic ulcer disease (PUD). The hopQII among patients with GC, CG, and PUD was also detected in 50%, 38.8%, and 39.3%, respectively. Moreover, sabA was diagnosed in 50% of patients with GC, 29.4% with CG, and 26.2% with PUD. Conclusions: No significant association was observed between hopQI, hopQII, and sabA genes with clinical outcomes. © 2018, Author(s).
Experts (# of related papers)
Other Related Docs